The activation of TNFR1 suppresses AMP-activated protein kinase (AMPK) activity and consequently causes intramuscular lipid accumulation, leading to lipotoxicity-mediated insulin resistance [38], all of which comprise the myocellular biological pathways of SO [39]. This evidence concerns the gene TNFRSF1A and Insulin resistance.